Minocycline has been found to reduce cerebral edema secondary to cerebral hemorrhage, promote
hematoma absorption, and shorten hematoma absorption time; clinical studies have been
conducted to confirm the safety in the treatment, but no significant hematoma absorption
effect was seen with short duration of drug use. Therefore, the investigators propose to
conduct a multicenter randomized controlled clinical trial to determine its accelerating
effect on hematoma absorption.
Phase:
Phase 1
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators:
The Fourth Affiliated Hospital of Zhejiang University School of Medicine The Second Affiliated Hospital of Jiaxing University